Press Releases

Featured Press Releases

BIO Statement Regarding Nomination of Robert F…

BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…

Learn more

BIO Released the Following Statement After…

“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…

Learn more

BIO Statement on Lawsuit Over 340B Rebates

BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…

Learn more

New Report Demonstrates High Costs and Low Benefits of Sarbanes-Oxley 404(b) Compliance for Emerging Biotechs

February 11, 2019

Washington, DC (February 11, 2019) – Today, to recognize National Inventors’ Day, the Biotechnology Innovation Organization (BIO) released a new report, “Science or Compliance: Will Section 404(b) Compliance Impede Innovation by Emerging Growth…

BIO Announces Brent Erickson to Step Down as Executive Vice President, Industrial and Environmental Section

February 11, 2019

The Biotechnology Innovation Organization (BIO) announced today that after 19 years leading the Industrial and Environmental Section, Executive Vice President Brent Erickson will step down from the organization in March 2019 to begin new business…

BIO Encouraged by Improved U.S. Ranking in Global Index of Patent System Strength

February 7, 2019

But New Legislative Proposals Endanger Progress

BIO Statement on Hatch-Waxman Integrity Act of 2019

February 6, 2019

BIO applauds the leadership of Senator Thom Tillis (R- NC) and Congressman Bill Flores (R-17 TX) for introducing the “Hatch-Waxman Integrity Act of 2019” to preserve the time-tested approach of the HWA while strengthening the ability of patent…

BIO Statement on State of the Union Address

February 5, 2019

BIO’s President and CEO Jim Greenwood issues statement on President Trump’s State of the Union Address.

BIO Statement on New Proposal for Lowering Out-of-Pocket Costs for Medicines

January 31, 2019

BIO’s President and CEO Jim Greenwood issued a statement after the Trump administration released a proposed rule that would alter safe harbor policies under the federal anti-kickback statute.

BIO Statement Ahead of Chinese Vice Premier Visit to Washington

January 29, 2019

"President Trump has taken unprecedented measures to take on China – our largest trading partner – for its history of trade abuses. Beijing has long imposed unjustified restrictions on U.S. companies seeking to do business in and export to China,…

BIO Statement on China Approvals of Agricultural Biotechnology Products

January 17, 2019

Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement on the announcement that the People’s Republic of China’s National Biosafety Committee approved the final safety certificate for five…

New Platform for Innovation in Food and Agriculture Launches, Invites Broad Conversation

January 16, 2019

WASHINGTON, DC – Jan. 16, 2019 – Today, the Biotechnology Innovation Organization (BIO) and the American Seed Trade Association (ASTA) jointly announce the launch of Innovature, a new platform to spark a thoughtful dialogue around innovation in food…

BIO Applauds House Passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act

January 11, 2019

“Members of the House have sent a strong signal to the American people about their commitment to prioritizing health security by providing the resources needed to fully prepare for and defend against biological threats. Strengthening the pipeline of…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.